The forward P/E of 5.9x is the most compelling finding; it places VRTS among the cheapest growth‑adjusted equity valuations in the industry, meaning any incremental earnings beat could trigger a disproportionate price rally.
A key risk is that the low forward P/E assumes earnings acceleration; a miss on the projected 12% growth could keep the multiple depressed and result in a downside of up to 15% if investors reassess the earnings outlook.
| Metric | Historical DCF | Analyst DCF |
|---|---|---|
| Growth Assumption | 2.5% (normalized) (10Y CAGR) | Analyst Rev × 36.4% margin |
| PV of FCF | $1.04B | $1.13B |
| Terminal Value (PV) | $6.37B | $6.76B |
| Enterprise Value | $7.41B | $7.89B |
| Equity Value | $5.04B | $5.52B |
| Implied Stock Price | $854.28 | $935.61 |
| Upside/Downside | +473.9% | +528.6% |
| WACC \ Growth | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 3.7% | $1469 | $1975 | $2902 | $5154 | $18665 |
| 4.7% | $884 | $1094 | $1401 | $1888 | $2780 |
| 5.7% | $577 | $690 | $838 | $1041 | $1336 |
| 6.7% | $388 | $458 | $543 | $652 | $794 |
| 7.7% | $261 | $307 | $362 | $428 | $510 |
| WACC \ Growth | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 3.7% | $1589 | $2126 | $3111 | $5504 | $19858 |
| 4.7% | $967 | $1191 | $1516 | $2033 | $2982 |
| 5.7% | $641 | $761 | $918 | $1134 | $1447 |
| 6.7% | $441 | $514 | $605 | $720 | $872 |
| 7.7% | $305 | $354 | $412 | $483 | $570 |
| Method | Implied Value | Upside/Downside | Basis |
|---|---|---|---|
| P/E (Peer) | $264.71 | +77.8% | Peer median P/E (10.5x) × Forward EPS ($25.19) |
| P/B (Peer) | $90.98 | -38.9% | Peer median P/B (0.73x) × Book Value per Share |
| EV/EBITDA (Peer) | $606.31 | +307.3% | Peer median EV/EBITDA (15.9x) × EBITDA - Net Debt |
| P/S (Peer) | $476.69 | +220.2% | Peer median P/S (4.30x) × Revenue per Share |
| DCF | $854.28 | +473.9% | Revenue × FCF Margin projection (normalized FCF) |
| Analyst Target | $135.67 | -8.9% | Consensus of 3 analysts |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-07-31 · finexus.net